127 related articles for article (PubMed ID: 22712861)
1. Seasonal variation in dysplastic naevi.
Welsch M; Marszalek R; Young M; Zhu J; Clarke L; Helm K
Clin Exp Dermatol; 2012 Jul; 37(5):554-6. PubMed ID: 22712861
[TBL] [Abstract][Full Text] [Related]
2. The significance of Melan-A-positive pagetoid melanocytosis in dysplastic nevi.
Huwait H; Hijazi N; Martinka M; Crawford RI
Am J Dermatopathol; 2014 Apr; 36(4):340-3. PubMed ID: 24736669
[TBL] [Abstract][Full Text] [Related]
3. The ultrastructure of dysplastic naevi: comparison with superficial spreading melanoma and common naevocellular naevi.
Langer K; Rappersberger K; Steiner A; Konrad K; Wolff K
Arch Dermatol Res; 1990; 282(6):353-62. PubMed ID: 2260880
[TBL] [Abstract][Full Text] [Related]
4. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
5. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ.
Kim J; Taube JM; McCalmont TH; Glusac EJ
J Cutan Pathol; 2011 Oct; 38(10):775-9. PubMed ID: 21797920
[TBL] [Abstract][Full Text] [Related]
6. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
[TBL] [Abstract][Full Text] [Related]
7. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
[TBL] [Abstract][Full Text] [Related]
8. The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers.
Quiohilag K; Caie P; Oniscu A; Brenn T; Harrison D
Virchows Arch; 2020 Jul; 477(1):121-130. PubMed ID: 32388720
[TBL] [Abstract][Full Text] [Related]
9. Fine structural and immunohistochemical properties of dysplastic melanocytic nevi: comparison with malignant melanoma.
Jimbow K; Horikoshi T; Takahashi H; Akutsu Y; Maeda K
J Invest Dermatol; 1989 May; 92(5 Suppl):304S-309S. PubMed ID: 2715663
[TBL] [Abstract][Full Text] [Related]
10. Melanoma associated with a dysplastic nevus: report of two cases with unusual sebocyte-like melanocytes in the nevus part of the lesion.
Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
Am J Dermatopathol; 2007 Dec; 29(6):566-7. PubMed ID: 18032954
[TBL] [Abstract][Full Text] [Related]
11. HMB-45 staining of dysplastic nevi. Support for a spectrum of progression toward melanoma.
Smoller BR; McNutt NS; Hsu A
Am J Surg Pathol; 1989 Aug; 13(8):680-4. PubMed ID: 2473661
[TBL] [Abstract][Full Text] [Related]
12. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB 45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma.
Orchard GE
Histochem J; 2000 Aug; 32(8):475-81. PubMed ID: 11095072
[TBL] [Abstract][Full Text] [Related]
13. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study.
Stierner U; Augustsson A; Rosdahl I; Suurküla M
Melanoma Res; 1992; 1(5-6):367-75. PubMed ID: 1422192
[TBL] [Abstract][Full Text] [Related]
14. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
[TBL] [Abstract][Full Text] [Related]
15. Melan-A positive dermal cells in malignant melanoma in situ.
Danga ME; Yaar R; Bhawan J
J Cutan Pathol; 2015 Jun; 42(6):388-93. PubMed ID: 25726939
[TBL] [Abstract][Full Text] [Related]
16. Relationship between season and diagnoses of melanocytic tumours.
Tronnier M; Müller C
Acta Derm Venereol; 2001 May; 81(2):112-5. PubMed ID: 11501647
[TBL] [Abstract][Full Text] [Related]
17. A quantitative comparison between SOX10 and MART-1 immunostaining to detect melanocytic hyperplasia in chronically sun-damaged skin.
Muzumdar S; Argraves M; Kristjansson A; Ferenczi K; Dadras SS
J Cutan Pathol; 2018 Apr; 45(4):263-268. PubMed ID: 29377259
[TBL] [Abstract][Full Text] [Related]
18. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall.
Pižem J; Nicholson KM; Mraz J; Prieto VG
Am J Surg Pathol; 2013 Aug; 37(8):1182-91. PubMed ID: 23715161
[TBL] [Abstract][Full Text] [Related]
20. Histological analysis of intraepidermal proliferations of atypical melanocytes.
Urso C; Giannini A; Bartolini M; Bondi R
Am J Dermatopathol; 1990 Apr; 12(2):150-5. PubMed ID: 2331049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
